- Home
- IXHL vs ICMB Comparison
IXHL vs ICMB Comparison
Compare IXHL & ICMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IXHL
- ICMB
- Stock Information
- Founded
- IXHL 2001
- ICMB 2012
- Country
- IXHL Australia
- ICMB United States
- Employees
- IXHL N/A
- ICMB N/A
- Industry
- IXHL
- ICMB Finance: Consumer Services
- Sector
- IXHL
- ICMB Finance
- Exchange
- IXHL Nasdaq
- ICMB Nasdaq
- Market Cap
- IXHL 35.6M
- ICMB 40.6M
- IPO Year
- IXHL N/A
- ICMB N/A
- Fundamental
- Price
- IXHL $0.58
- ICMB $2.92
- Analyst Decision
- IXHL
- ICMB
- Analyst Count
- IXHL 0
- ICMB 0
- Target Price
- IXHL N/A
- ICMB N/A
- AVG Volume (30 Days)
- IXHL 117.4M
- ICMB 25.8K
- Earning Date
- IXHL 09-29-2025
- ICMB 08-12-2025
- Dividend Yield
- IXHL N/A
- ICMB 16.44%
- EPS Growth
- IXHL N/A
- ICMB N/A
- EPS
- IXHL N/A
- ICMB 0.93
- Revenue
- IXHL $98,000.00
- ICMB $20,422,069.00
- Revenue This Year
- IXHL $2,538.49
- ICMB N/A
- Revenue Next Year
- IXHL $249.95
- ICMB N/A
- P/E Ratio
- IXHL N/A
- ICMB $3.14
- Revenue Growth
- IXHL N/A
- ICMB N/A
- 52 Week Low
- IXHL $0.08
- ICMB $2.46
- 52 Week High
- IXHL $3.12
- ICMB $3.47
- Technical
- Relative Strength Index (RSI)
- IXHL 51.37
- ICMB 60.24
- Support Level
- IXHL $0.51
- ICMB $2.88
- Resistance Level
- IXHL $0.92
- ICMB $2.97
- Average True Range (ATR)
- IXHL 0.09
- ICMB 0.08
- MACD
- IXHL -0.00
- ICMB 0.01
- Stochastic Oscillator
- IXHL 37.18
- ICMB 61.76
About IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.
About ICMB Investcorp Credit Management BDC Inc.
Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). Its investment objective is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.